↧
Image may be NSFW.
Clik here to view.
Clik here to view.
Update on U.S. Biotech Bailout
Yesterday the U.S. House of Representatives’ Ways and Means Committee approved the “American Recovery and Reinvestment Plan,” (pdf) which did not include tax stimulus incentives proposed by the...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Pharma / Biotech R&D Budgets – A Proposal For Measuring Performance
During the BioFinance 2011 conference held in Toronto last week, one presenter showed a slide that outlined the number of new chemical entities (NCEs) approved by the FDA over a number of years. Since...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Deloitte and Thomson Reuters Follow Up on R&D Value
An interesting follow-up study conducted by Thomson Reuters & Deloitte delving into what many in the industry have sought to understand better. Last year Deloitte and Thomson Reuters conducted an...
View Article
